UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
November
30, 2009
Date
of Report (date of earliest event reported)
Cutera,
Inc.
(Exact
name of Registrant as specified in its charter)
|
Delaware
|
000-50644
|
77-0492262
|
||
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer
Identification
No.)
|
3240
Bayshore Blvd.
Brisbane,
California 94005
(Address
of principal executive offices)
(415)
657-5500
(Registrant’s
telephone number, including area code)
N/A
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
|
|
[_]
Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|
|
|
[_]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
|
[_]
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[_]
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
|
Item
8.01. Other
Events.
On
November 30, 2009, Cutera, Inc. (the “Company”) issued a press release relating
to its TruSculpt body contouring product. A copy of the press release
is furnished as Exhibit 99.1 to this Form 8-K.
Item
9.01. Financial
Statements and Exhibits.
(d)
Exhibits.
Exhibit
No. Description
99.1
Press Release of Cutera, Inc. dated as of November 30, 2009.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
CUTERA,
INC.
|
|||
|
Date: November
30, 2009.
|
By:
|
/s/
Kevin P. Connors
|
|
|
Kevin
P. Connors
President
and Chief Executive Officer
|
|||
FOR
IMMEDIATE RELEASE
CONTACTS:
Cutera,
Inc.
Ron
Santilli
Chief
Financial Officer
415-657-5500
Investor
Relations
John
Mills
Integrated
Corporate Relations, Inc.
310-954-1100
john.mills@icrinc.com
BRISBANE,
Calif., November 30, 2009 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq:CUTR - News), a leading
provider of laser and other energy-based aesthetic systems for practitioners
worldwide, announced today that it is postponing indefinitely the release of its
TruSculpt body contouring product.
Kevin
Connors, CEO commented “We have had the opportunity to review recent clinical
data from our research and have determined that established clinical protocols
have not yielded the desired outcome. We believe the potential market for
non-invasive body contouring is very large, however, our standards for product
performance are higher than is commercially available. We have a strong history
of introducing leading products with a high level of clinical efficacy that
ensure customer success.
He
concluded, “We will continue our research efforts, including the monitoring of
our clinical sites, and will commercialize the technology, if and when, it has
met the standards our customers have come to expect from us. This decision will
allow us to redirect some of our resources on other exciting development
projects.”
About
Cutera, Inc.
Brisbane,
California-based Cutera is a leading provider of laser and other energy-based
aesthetic systems for practitioners worldwide. Since 1998, Cutera has been
developing innovative, easy-to-use products that enable physicians and other
qualified practitioners to offer safe and effective aesthetic treatments to
their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.